Drugs / Nigella sativa seed
Nigella sativa seed
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00327054 | Feb 2006 → Mar 2007 | diabetes mellitus, hyperlipidemia, hypertensive disorder, metabolic syndrome X | Aga Khan University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT04686461 | Oct 2019 → Jan 2021 | — | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT04767087 Comparator | Mar 2021 → Feb 2022 | COVID-19 | Sohaib Ashraf | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nigella sativa seed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00327054 ↗ |
| Known as | Kalonji | “Half of the respondents received powdered N. sativa (Kalonji) seed in capsule and the rest received a placebo.” PMID 19500003 ↗ Jun 2009 |
| Known as | N. sativa | “Half of the respondents received powdered N. sativa (Kalonji) seed in capsule and the rest received a placebo.” PMID 19500003 ↗ Jun 2009 |
| Known as | Nigella sativa seed extract | “Nigella sativa seed extract, bee wax, white petrolatum, stearyl alcohol” NCT04686461 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The seed extracts from Nigella sativa is used by Unani physicians of traditional medicine (Hakims or Tabibs) and Ayurvedic practitioners (Vaids) in the treatment of several...” PMID 19500003 ↗ Jun 2009 |
| Route | Topical | “Then a topical ointment will be prepared from Nigella sativa extract and supplied to the arsenical keratosis patient at two weeks interval.” NCT04686461 ↗ |